Lexicon Pharmaceuticals
LXRX
#6201
Rank
S$1.31 B
Marketcap
S$2.96
Share price
-0.22%
Change (1 day)
91.67%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Net assets

Net assets on the balance sheet as of March 2026 : S$0.26 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has S$0.26 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lexicon Pharmaceuticals - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$S$0.13 B-30.4%
2024-12-31$S$0.19 B61.33%
2023-12-31$S$0.12 B-21.68%
2022-12-31$S$0.15 B2.24%
2021-12-31$S$0.15 B-25.76%
2020-12-31$S$0.20 B31.04%
2019-12-31$S$0.15 B-537.65%
2018-12-31$-S$36.08 Million-139.51%
2017-12-31$S$91.3 M-59.92%
2016-12-31$S$0.22 B-43.66%
2015-12-31$S$0.40 B7.74%
2014-12-31$S$0.37 B74.07%
2013-12-31$S$0.21 B-33.89%
2012-12-31$S$0.32 B-15.37%
2011-12-31$S$0.38 B21.11%
2010-12-31$S$0.31 B38.63%
2009-12-31$S$0.22 B-18.04%
2008-12-31$S$0.28 B-32.09%
2007-12-31$S$0.41 B214.53%
2006-12-31$S$0.13 B-8.23%
2005-12-31$S$0.14 B-27.98%
2004-12-31$S$0.19 B-29.76%
2003-12-31$S$0.28 B-4.21%
2002-12-31$S$0.29 B-27.07%
2001-12-31$S$0.40 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Thermo Fisher Scientific
TMO
S$67.18 B 25,564.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$3.45 B 1,219.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$40.55 B 15,390.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-S$0.3 Billion-212.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$1.28 B 391.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-S$0.4 Billion-251.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-S$0.22 Billion-180.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$8.01 B 2,962.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$8.85 M-96.62%๐Ÿ‡บ๐Ÿ‡ธ USA